Affordable Insulin Now Act of 2023
- Last Action
- 11/30/2023
Actions
- 2023-11-30Committee on Banking, Housing, and Urban Affairs. Hearings held. Hearings printed: S.Hrg. 118-511.
- 2023-03-23Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-03-23Introduced in Senate
CRS Summary
As of 2023-03-23 (00)
Affordable Insulin Now Act of 2023
This bill limits cost-sharing for insulin under private health insurance and establishes a program to provide insulin to individuals without insurance.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.
Further, the Department of Health and Human Services (HHS) must enter into agreements with pharmacies or health care providers to provide insulin to individuals without insurance. HHS must pay such pharmacies or providers an amount equal to the difference between the out-of-pocket cost to the individual for a 30-day supply of such insulin products and $35.
Cosponsors (11)
- John Kennedy (R-LA)
- John Fetterman (D-PA)
- Katie Britt (R-AL)
- Gary Peters (D-MI)
- Tommy Tuberville (R-AL)
- Mike Braun (R-IN)
- Jacklyn Rosen (D-NV)
- J. Vance (R-OH)
- Bob Casey (D-PA)
- Josh Hawley (R-MO)
- Elizabeth Warren (D-MA)
Subjects
- Health care costs and insurance
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.